TP53 and cancer: Since HεdC may epigenetically alter gene accumulation and is also known to be highly mutagenic [14], this contributes to the persistent inflammation or, through p53 mutations or alternation of gene expression, may be associated with an increase in the incidence of cancer seen in RA patients [28, 29].